By Amr Khalifa (Amr Khalifa)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Low Density Lipoprotein

Skeletal Muscle

Top Venues

Nature communications

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

By Amr Khalifa, Ana Guijarro, Alessio Nencioni
Advances in Diet and Physical Activity in Breast Cancer Prevention and Treatment. Nutrients 16 (14) (2024)
By Amr Khalifa, Ana Guijarro, Alessio Nencioni
Advances in Diet and Physical Activity in Breast Cancer Prevention and Treatment. Nutrients 16 (14) (2024)
By Amr Khalifa, Ana Guijarro, Alessio Nencioni
Advances in Diet and Physical Activity in Breast Cancer Prevention and Treatment. Nutrients 16 (14) (2024)
By Amr Khalifa, Ana Guijarro, Silvia Ravera, Nadia Bertola, Maria Pia Adorni, Bianca Papotti, Lizzia Raffaghello, Roberto Benelli, Pamela Becherini, Asmaa Namatalla, Daniela Verzola, Daniele Reverberi, Fiammetta Monacelli, Michele Cea, Livia Pisciotta, Franco Bernini, Irene Caffa, Alessio Nencioni
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity. Nature communications 14 (1) (2023)
By Amr Khalifa, Ana Guijarro, Silvia Ravera, Nadia Bertola, Maria Pia Adorni, Bianca Papotti, Lizzia Raffaghello, Roberto Benelli, Pamela Becherini, Asmaa Namatalla, Daniela Verzola, Daniele Reverberi, Fiammetta Monacelli, Michele Cea, Livia Pisciotta, Franco Bernini, Irene Caffa, Alessio Nencioni
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity. Nature communications 14 (1) (2023)
Moustafa S Ghanem, Irene Caffa, Alberto Del Rio, Jorge Franco, Marco Daniele Parenti, Fiammetta Monacelli, Michele Cea, By Amr Khalifa, Aimable Nahimana, Michel A Duchosal, Silvia Ravera, Nadia Bertola, Santina Bruzzone, Alessio Nencioni, Francesco Piacente
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)